Search clinical trials for: B cell NHL, Phase 1/2,GB261,bispecific antibody,CD20/CD3
Total 487895 results
-
GenmabAbbVieRecruitingFollicular Lymphoma | Diffuse Large B-Cell LymphomaUnited States, France, Italy, Spain, United Kingdom, Belgium, Denmark, Netherlands, Finland, Czechia, Sweden, Australia, Norway
-
Genor Biopharma Co., Ltd.RecruitingCLL | B Cell NHLAustralia
-
GenmabAbbVieRecruitingSmall Lymphocytic Lymphoma | Richter's Syndrome | Relapsed/Refractory Chronic Lymphocytic LeukemiaUnited States, Belgium, Netherlands, Spain, Italy, Australia, Israel, France, Denmark, Czechia, Germany, United Kingdom
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Acute Leukemia | Recurrent Acute Lymphoblastic Leukemia | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Refractory Acute Lymphoblastic Leukemia | Systemic Mastocytosis | Recurrent Hematologic Malignancy | Hairy Cell Leukemia | Chronic... and other conditions
-
Guangzhou Excelmab Inc.RecruitingSafety and Efficacy of EX103 in Subjects With Relapsed/Refractory CD20-Positive Non-Hodgkin LymphomaCD20-positive Non-Hodgkin LymphomaChina
-
University of WashingtonGenentech, Inc.RecruitingMarginal Zone Lymphoma | Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Indolent B-Cell Non-Hodgkin Lymphoma | Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Refractory Extranodal Marginal Zone...United States
-
Christian BuskeRoche Pharma AG; University of Ulm; Zentrum für Klinische Studien Ulm; X-act Cologne... and other collaboratorsActive, not recruiting
-
PfizerHoffmann-La RocheRecruitingDiffuse Large B-Cell LymphomaTaiwan, United States, Japan
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)Withdrawn
-
Shanghai Miracogen Inc.RecruitingRelapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)China
-
National Institute of Allergy and Infectious Diseases...Autoimmunity Centers of ExcellenceCompleted
-
Medical College of WisconsinMidwest Athletes Against Childhood CancerNot yet recruitingLymphoma | Leukemia | Hodgkin Disease | CD30-Positive Diffuse Large B-Cell Lymphoma | CD30+ Anaplastic Large Cell Lymphoma | CD30+ Pleomorphic Large T-Cell Cutaneous Lymphoma | CD30+ Immunoblastic Large T-Cell Cutaneous LymphomaUnited States
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)Canada, United States, Korea, Republic of, Australia, Japan, Italy, Brazil, Germany, France, China, Israel
-
Janssen Research & Development, LLCRecruitingLymphoma, Non-Hodgkin | Leukemia, Lymphocytic, Chronic, B-CellUnited States, China, France, Denmark, Israel, Poland, Australia
-
National Institute of Allergy and Infectious Diseases...University of Pittsburgh; PPDCompletedPrimary Immunodeficiency | PIDUnited States
-
AZ-VUBKU Leuven; Universiteit Antwerpen; Erasme University HospitalCompletedDiabetes Mellitus, Type 1Belgium, Germany
-
Beijing Friendship HospitalEnrolling by invitation
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Tiziana Life Sciences LTDWithdrawn
-
Novartis PharmaceuticalsTerminatedLeukaemia, Lymphocytic, ChronicBelgium, Netherlands, United States, Argentina, Czechia, Denmark, France, Greece, Israel, Russian Federation, Sweden, Korea, Republic of, Australia, Brazil, Canada, Italy, Spain, Turkey, Hungary, Finland, Poland, Ukraine, Puerto Rico, Indi... and more
-
Probiomed S.A. de C.V.UnknownDiffuse Large B Cell LymphomaMexico
-
BiocadCompleted
-
Mentrik Biotech, LLCUnknownPreviously Treated CD20+ B-cell MalignanciesUnited States
-
The Lymphoma Academic Research OrganisationRoche Pharma AGRecruitingFollicular LymphomaFrance
-
Han weidongUnknown
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)Terminated
-
GlaxoSmithKlineJuvenile Diabetes Research FoundationCompletedDiabetes Mellitus, Type 1Italy
-
Memorial Sloan Kettering Cancer CenterAdaptive BiotechnologiesRecruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)United States
-
TakedaTerminatedRheumatoid ArthritisUnited States, Argentina, Canada, Czech Republic, Germany, Hungary, Italy, Mexico, Poland, Spain, United Kingdom
-
Brian JonasNational Cancer Institute (NCI); Pharmacyclics LLC.RecruitingPhiladelphia Chromosome Positive | Adult B Acute Lymphoblastic LeukemiaUnited States
-
Regeneron PharmaceuticalsRecruitingRelapsed Refractory Multiple Myeloma (RRMM)Canada, United States, Korea, Republic of, Israel, Spain, Australia, Brazil, United Kingdom, Poland, Taiwan, Singapore, France, Italy
-
ITabMed Co., Ltd.Not yet recruitingRecurrent or Metastatic Solid Tumors
-
EVIVE BiotechnologyPeking University Cancer Hospital & InstituteUnknownRelapsed or Refractory B-cell Lymphoma
-
Washington University School of MedicineGenentech, Inc.RecruitingDiffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Transformed B-Cell Lymphoma | Follicular Lymphoma Grade 3BUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingB Acute Lymphoblastic Leukemia | Philadelphia Chromosome Positive | Minimal Residual Disease | Adult Acute Lymphoblastic Leukemia in Complete RemissionUnited States
-
UCB Biopharma SRLRecruitingMyelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)United States, Australia, Belgium, Czechia, France, Germany, Italy, Japan, Korea, Republic of, Mexico, Spain, Sweden, Switzerland, Turkey, Portugal, United Kingdom, Brazil, Ukraine, Taiwan
-
McGill University Health Centre/Research Institute...McGill UniversityTerminatedSafety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS)Complex Regional Pain SyndromesCanada
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.RecruitingRelapsed/Refractory Multiple MyelomaUnited States, France
-
Cambridge Antibody TechnologyUnknownLeukemia | Hairy Cell Leukemia | HCLUnited States, Poland, United Kingdom
-
PfizerCompletedMultiple MyelomaCanada, United States
-
Heidelberg UniversityRecruitingEarly Stage Follicular Lymphoma WHO Grade 1/2 or 3aGermany
-
The Lymphoma Academic Research OrganisationInstitute of Cancer Research, United KingdomRecruitingMantle Cell LymphomaFrance, United Kingdom, Belgium
-
Haukeland University HospitalCompletedChronic Fatigue Syndrome | Myalgic EncephalomyelitisNorway
-
MedImmune LLCCambridge Antibody TechnologyCompletedHairy Cell LeukemiaUnited States, Poland
-
Cambridge Antibody TechnologyUnknownLeukemia | Non-Hodgkin's Lymphoma | NHLUnited States, Poland
-
MedImmune LLCCambridge Antibody TechnologySuspendedLymphoma | LeukemiaUnited States
-
Chinese PLA General HospitalUnknownAdvanced HER-2 Positive Solid Tumors | Chemotherapy Refactory | HER-2 Antibody Inhibitor Therapy RefactoryChina
-
Kazakhstan's Medical University "KSPH"Vyacheslav Notanovich Lokshin; Nurgalieva Zhanar Zhenisovna; Manzhuova Lyazzat... and other collaboratorsCompletedChild Development | Health Status | Children Born After Assisted Reproductive TechnologiesKazakhstan
-
Y-mAbs TherapeuticsChildren's Oncology GroupTerminatedAML, ChildhoodUnited States
-
Olivia Newton-John Cancer Research InstituteAustin Health; Roche Products Pty Limited; Ballarat Health ServicesActive, not recruitingFollicular LymphomaAustralia